Report Detail
Global Antivirals Market Insights and Forecast to 2026
- RnM4132871 |
- 13 August, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Antivirals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antivirals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antivirals market is segmented into
Generic
Branded
Segment by Application, the Antivirals market is segmented into
HIV
Hepatitis
HSV
Influenza
Regional and Country-level Analysis
The Antivirals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antivirals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antivirals Market Share Analysis
Antivirals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antivirals business, the date to enter into the Antivirals market, Antivirals product introduction, recent developments, etc.
The major vendors covered:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s
1 Study Coverage
- 1.1 Antivirals Product Introduction
- 1.2 Market Segments
- 1.3 Key Antivirals Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Antivirals Market Size Growth Rate by Type
- 1.4.2 Generic
- 1.4.3 Branded
- 1.5 Market by Application
- 1.5.1 Global Antivirals Market Size Growth Rate by Application
- 1.5.2 HIV
- 1.5.3 Hepatitis
- 1.5.4 HSV
- 1.5.5 Influenza
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antivirals Market Size, Estimates and Forecasts
- 2.1.1 Global Antivirals Revenue 2015-2026
- 2.1.2 Global Antivirals Sales 2015-2026
- 2.2 Global Antivirals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Antivirals Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Antivirals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antivirals Competitor Landscape by Players
- 3.1 Antivirals Sales by Manufacturers
- 3.1.1 Antivirals Sales by Manufacturers (2015-2020)
- 3.1.2 Antivirals Sales Market Share by Manufacturers (2015-2020)
- 3.2 Antivirals Revenue by Manufacturers
- 3.2.1 Antivirals Revenue by Manufacturers (2015-2020)
- 3.2.2 Antivirals Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Antivirals Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Antivirals Revenue in 2019
- 3.2.5 Global Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Antivirals Price by Manufacturers
- 3.4 Antivirals Manufacturing Base Distribution, Product Types
- 3.4.1 Antivirals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antivirals Product Type
- 3.4.3 Date of International Manufacturers Enter into Antivirals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Antivirals Market Size by Type (2015-2020)
- 4.1.1 Global Antivirals Sales by Type (2015-2020)
- 4.1.2 Global Antivirals Revenue by Type (2015-2020)
- 4.1.3 Antivirals Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Antivirals Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Antivirals Sales Forecast by Type (2021-2026)
- 4.2.2 Global Antivirals Revenue Forecast by Type (2021-2026)
- 4.2.3 Antivirals Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Antivirals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Antivirals Market Size by Application (2015-2020)
- 5.1.1 Global Antivirals Sales by Application (2015-2020)
- 5.1.2 Global Antivirals Revenue by Application (2015-2020)
- 5.1.3 Antivirals Price by Application (2015-2020)
- 5.2 Antivirals Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Antivirals Sales Forecast by Application (2021-2026)
- 5.2.2 Global Antivirals Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Antivirals Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Antivirals by Country
- 6.1.1 North America Antivirals Sales by Country
- 6.1.2 North America Antivirals Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Antivirals Market Facts & Figures by Type
- 6.3 North America Antivirals Market Facts & Figures by Application
7 Europe
- 7.1 Europe Antivirals by Country
- 7.1.1 Europe Antivirals Sales by Country
- 7.1.2 Europe Antivirals Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antivirals Market Facts & Figures by Type
- 7.3 Europe Antivirals Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Antivirals by Region
- 8.1.1 Asia Pacific Antivirals Sales by Region
- 8.1.2 Asia Pacific Antivirals Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Antivirals Market Facts & Figures by Type
- 8.3 Asia Pacific Antivirals Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Antivirals by Country
- 9.1.1 Latin America Antivirals Sales by Country
- 9.1.2 Latin America Antivirals Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Antivirals Market Facts & Figures by Type
- 9.3 Central & South America Antivirals Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Antivirals by Country
- 10.1.1 Middle East and Africa Antivirals Sales by Country
- 10.1.2 Middle East and Africa Antivirals Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Antivirals Market Facts & Figures by Type
- 10.3 Middle East and Africa Antivirals Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Antivirals Products Offered
- 11.1.5 Merck Related Developments
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Corporation Information
- 11.2.2 Johnson & Johnson Description and Business Overview
- 11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Johnson & Johnson Antivirals Products Offered
- 11.2.5 Johnson & Johnson Related Developments
- 11.3 Teva Pharmaceutical Industries
- 11.3.1 Teva Pharmaceutical Industries Corporation Information
- 11.3.2 Teva Pharmaceutical Industries Description and Business Overview
- 11.3.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Teva Pharmaceutical Industries Antivirals Products Offered
- 11.3.5 Teva Pharmaceutical Industries Related Developments
- 11.4 GSK
- 11.4.1 GSK Corporation Information
- 11.4.2 GSK Description and Business Overview
- 11.4.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 GSK Antivirals Products Offered
- 11.4.5 GSK Related Developments
- 11.5 Mylan
- 11.5.1 Mylan Corporation Information
- 11.5.2 Mylan Description and Business Overview
- 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Mylan Antivirals Products Offered
- 11.5.5 Mylan Related Developments
- 11.6 Gilead Sciences
- 11.6.1 Gilead Sciences Corporation Information
- 11.6.2 Gilead Sciences Description and Business Overview
- 11.6.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Gilead Sciences Antivirals Products Offered
- 11.6.5 Gilead Sciences Related Developments
- 11.7 F. Hoffmann-La Roche
- 11.7.1 F. Hoffmann-La Roche Corporation Information
- 11.7.2 F. Hoffmann-La Roche Description and Business Overview
- 11.7.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 F. Hoffmann-La Roche Antivirals Products Offered
- 11.7.5 F. Hoffmann-La Roche Related Developments
- 11.8 Bristol-Myers-Squibb
- 11.8.1 Bristol-Myers-Squibb Corporation Information
- 11.8.2 Bristol-Myers-Squibb Description and Business Overview
- 11.8.3 Bristol-Myers-Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bristol-Myers-Squibb Antivirals Products Offered
- 11.8.5 Bristol-Myers-Squibb Related Developments
- 11.9 AbbVie
- 11.9.1 AbbVie Corporation Information
- 11.9.2 AbbVie Description and Business Overview
- 11.9.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 AbbVie Antivirals Products Offered
- 11.9.5 AbbVie Related Developments
- 11.10 Aurobindo Pharma
- 11.10.1 Aurobindo Pharma Corporation Information
- 11.10.2 Aurobindo Pharma Description and Business Overview
- 11.10.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Aurobindo Pharma Antivirals Products Offered
- 11.10.5 Aurobindo Pharma Related Developments
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Antivirals Products Offered
- 11.1.5 Merck Related Developments
- 11.12 Dr Reddy’s
- 11.12.1 Dr Reddy’s Corporation Information
- 11.12.2 Dr Reddy’s Description and Business Overview
- 11.12.3 Dr Reddy’s Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Dr Reddy’s Products Offered
- 11.12.5 Dr Reddy’s Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Antivirals Market Estimates and Projections by Region
- 12.1.1 Global Antivirals Sales Forecast by Regions 2021-2026
- 12.1.2 Global Antivirals Revenue Forecast by Regions 2021-2026
- 12.2 North America Antivirals Market Size Forecast (2021-2026)
- 12.2.1 North America: Antivirals Sales Forecast (2021-2026)
- 12.2.2 North America: Antivirals Revenue Forecast (2021-2026)
- 12.2.3 North America: Antivirals Market Size Forecast by Country (2021-2026)
- 12.3 Europe Antivirals Market Size Forecast (2021-2026)
- 12.3.1 Europe: Antivirals Sales Forecast (2021-2026)
- 12.3.2 Europe: Antivirals Revenue Forecast (2021-2026)
- 12.3.3 Europe: Antivirals Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Antivirals Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Antivirals Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Antivirals Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Antivirals Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Antivirals Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Antivirals Sales Forecast (2021-2026)
- 12.5.2 Latin America: Antivirals Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Antivirals Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Antivirals Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Antivirals Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Antivirals Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Antivirals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Antivirals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antivirals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antivirals. Industry analysis & Market Report on Antivirals is a syndicated market report, published as Global Antivirals Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Antivirals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
